GL1X · GenesisL1 explorer

MolNFT v1 · #175897 · protein

Spua mutant - H221N with glu

7D53 · Probable glutamine amidotransferase: “Spua mutant - H221N with glu”. X-ray diffraction, 2 ligands (GLU, MG), 7 pockets (best druggability 0.74). MolNFT v1 #175897 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7D53
Type
protein
Length
992 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Probable glutamine amidotransferase
UniProt
Q9I6J4
Ligands
GLU, MG
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 3 distinct chains · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, DProbable glutamine amidotransferaseprotein24933% helix, 24% strandQ9I6J4
BProbable glutamine amidotransferaseprotein24635% helix, 24% strandQ9I6J4
CProbable glutamine amidotransferaseprotein24834% helix, 24% strandQ9I6J4

Ligands and binding sites

  • GLU · Glutamic acid · ligand · 4 copies · chains A, B, C, D
  • MG · Magnesium ion · metal · 4 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18160.740.7970empty
23920.660.7953empty
34020.630.7856GLU
42680.610.8038GLU
51880.490.7638GLU

Interfaces

5 interfaces between chains.

  • A–B · 1579 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 317 Ų buried · 2 hydrogen bonds · protein-protein
  • B–D · 268 Ų buried · 3 hydrogen bonds · protein-protein
  • C–D · 153 Ų buried · 0 hydrogen bonds · protein-protein
  • A–D · 34 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 7D53 · SpuA mutant - H221N with Glu · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.